Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

HIV-1 adaptation to NK-cell-mediated immune pressure.

Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, Martin M, Li B, Khakoo SI, Carrington M, Allen TM, Altfeld M.

Nature. 2011 Aug 3;476(7358):96-100. doi: 10.1038/nature10237.

2.

Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.

von Bredow B, Arias JF, Heyer LN, Gardner MR, Farzan M, Rakasz EG, Evans DT.

J Virol. 2015 Oct;89(20):10648-55. doi: 10.1128/JVI.01911-15. Epub 2015 Aug 12.

3.

Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.

O'Connell KA, Han Y, Williams TM, Siliciano RF, Blankson JN.

J Virol. 2009 May;83(10):5028-34. doi: 10.1128/JVI.02551-08. Epub 2009 Feb 11.

4.

Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.

Jennes W, Verheyden S, Mertens JW, Camara M, Seydi M, Dieye TN, Mboup S, Demanet C, Kestens L.

Blood. 2013 Feb 14;121(7):1157-64. doi: 10.1182/blood-2012-09-455352. Epub 2012 Dec 13.

5.

The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

Matusali G, Potestà M, Santoni A, Cerboni C, Doria M.

J Virol. 2012 Apr;86(8):4496-504. doi: 10.1128/JVI.05788-11. Epub 2012 Feb 1.

6.

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, Lifson JD, Allen TM, Carrington M, Altfeld M.

J Exp Med. 2007 Nov 26;204(12):3027-36. Epub 2007 Nov 19.

7.

Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.

Hölzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, Mann JK, Jaggernath M, Kang SG, Körner C, Chung AW, Schafer JL, Evans DT, Alter G, Walker BD, Goulder PJ, Carrington M, Hartmann P, Pertel T, Zhou R, Ndung'u T, Altfeld M.

PLoS Med. 2015 Nov 17;12(11):e1001900; discussion e1001900. doi: 10.1371/journal.pmed.1001900. eCollection 2015 Nov.

8.

Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.

Tiemessen CT, Paximadis M, Minevich G, Winchester R, Shalekoff S, Gray GE, Sherman GG, Coovadia AH, Kuhn L.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):181-9. doi: 10.1097/QAI.0b013e3182174a76.

9.

Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.

Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, Carlson J, Kadie C, Bhattacharya T, Chui C, Szinger J, Mo T, Hogg RS, Montaner JS, Frahm N, Brander C, Walker BD, Harrigan PR.

PLoS Pathog. 2007 Jul;3(7):e94. Erratum in: PLoS Pathog. 2007 Aug 10;3(8):e121.

10.

HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.

Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M.

J Virol. 2015 May;89(10):5687-700. doi: 10.1128/JVI.00611-15. Epub 2015 Mar 11.

11.

HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

Fadda L, Körner C, Kumar S, van Teijlingen NH, Piechocka-Trocha A, Carrington M, Altfeld M.

PLoS Pathog. 2012;8(7):e1002805. doi: 10.1371/journal.ppat.1002805. Epub 2012 Jul 12.

12.

Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers.

Omosun YO, Blackstock AJ, Gatei W, Hightower A, van Eijk AM, Ayisi J, Otieno J, Lal RB, Steketee R, Nahlen B, ter Kuile FO, Slutsker L, Shi YP.

PLoS One. 2012;7(6):e38617. doi: 10.1371/journal.pone.0038617. Epub 2012 Jun 8.

13.

Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.

Veillette M, Désormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, Haynes BF, Robinson JE, Kaufmann DE, Bonsignori M, Sodroski J, Finzi A.

J Virol. 2014 Mar;88(5):2633-44. doi: 10.1128/JVI.03230-13. Epub 2013 Dec 18.

14.

Innate immune control of HIV.

Carrington M, Alter G.

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a007070. doi: 10.1101/cshperspect.a007070. Review.

15.

HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Song R, Lisovsky I, Lebouché B, Routy JP, Bruneau J, Bernard NF.

PLoS Pathog. 2014 Jan;10(1):e1003867. doi: 10.1371/journal.ppat.1003867. Epub 2014 Jan 16.

16.

Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.

Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, Carrington M, Deeks SG, Montaner LJ.

AIDS. 2012 Sep 24;26(15):1869-78.

17.

Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.

Mantegani P, Tambussi G, Galli L, Din CT, Lazzarin A, Fortis C.

Immunology. 2010 Feb;129(2):220-33. doi: 10.1111/j.1365-2567.2009.03171.x. Epub 2009 Aug 4.

18.

Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control.

Luteijn R, Sciaranghella G, van Lunzen J, Nolting A, Dugast AS, Ghebremichael MS, Altfeld M, Alter G.

Eur J Immunol. 2011 Sep;41(9):2729-40. doi: 10.1002/eji.201040886. Epub 2011 Aug 12.

19.

The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.

Brown BK, Wieczorek L, Kijak G, Lombardi K, Currier J, Wesberry M, Kappes JC, Ngauy V, Marovich M, Michael N, Ochsenbauer C, Montefiori DC, Polonis VR.

PLoS One. 2012;7(4):e29454. doi: 10.1371/journal.pone.0029454. Epub 2012 Apr 11.

20.

HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.

Alvarez RA, Hamlin RE, Monroe A, Moldt B, Hotta MT, Rodriguez Caprio G, Fierer DS, Simon V, Chen BK.

J Virol. 2014 Jun;88(11):6031-46. doi: 10.1128/JVI.00449-14. Epub 2014 Mar 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk